Activist investor Carl Icahn has taken a small stake in Allergan, joining a growing list of weighty shareholders who could influence the company’s strategy at a time when investors are pushing for changes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,